A carregar...

Influence of statin use on the incidence of recurrent venous thromboembolism and major bleeding in patients receiving rivaroxaban or standard anticoagulant therapy

BACKGROUND: Statins may reduce the risk of first and recurrent venous thromboembolism (VTE). No data are available on their potential benefit in patients treated with the oral anticoagulant rivaroxaban. METHODS: The EINSTEIN DVT/PE and EINSTEIN Extension studies compared rivaroxaban with standard of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thromb J
Main Authors: Wells, Philip S, Gebel, Martin, Prins, Martin H, Davidson, Bruce L, Lensing, Anthonie WA
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4334416/
https://ncbi.nlm.nih.gov/pubmed/25698905
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-9560-12-26
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!